The Microbiome and GLP-1 Drugs

GLP-1 (glucagon-like peptide-1) receptor agonist drugs (Ozempic, Wegovy, Zepbound) have emerged as a significant advancement in the treatment of obesity and Type 2 Diabetes due to their ability to regulate blood sugar levels and suppress appetite. Recent research suggests that the gut microbiome may play a crucial role in mediating the efficacy and mechanisms of these drugs. In this post, we’ll explore the intricate relationship between GLP-1 drugs and the microbiome.

GLP-1 is a type of hormone called an incretin hormone. It’s naturally produced in the gut and works by enhancing insulin secretion in response to food intake. Insulin is the hormone that helps your cells use the sugar from your food for energy. In addition to its incretin effect, GLP-1 slows gastric emptying, which promotes reduced appetite. It also inhibits glucagon release, leading to lower blood glucose levels. These GLP-1 receptor agonists mimic the action of natural GLP-1, helping with obesity and Type 2 Diabetes. Currently, these drugs are only administered as an injection. GLP-1 receptors in the brain play a key role in regulating appetite, linking the central nervous system to metabolic control.

The gut microbiome, comprising trillions of microorganisms inhabiting our gut, plays a pivotal role in energy homeostasis, fat storage and metabolic regulation. People with obesity tend to have distinct patterns of gut bacteria species, Studies have demonstrated a relative increase in Firmacutes phyla along with a decrease in the proportion of Bacteroidetes in obese when compared to lean individuals. These bacterial species are associated with increased energy extraction from food, meaning that an ‘obese’ gut microbiome is actually more efficient at harvesting energy than a healthy gut microbiome. This may be part of why two people eating the same foods can extract different amounts of energy from the foods. Obesity also indirectly affects aspects of gut health such as intestinal wall permeability, fatty acid uptake and bile acid metabolism. 

Conversely, a diverse and balanced microbiome supports metabolic health through mechanisms such as fermentation of soluble dietary fibers into short-chain fatty acids (SCFAs), which naturally  influence appetite suppression and insulin sensitivity through endogenous production of GLP-1.

The microbiome can influence appetite regulation. SCFAs, produced by the fermentation of dietary fibers by gut bacteria, stimulate the release of appetite-suppressing hormones like peptide YY (PYY) and GLP-1 itself. In mice, the short-chain fatty acids acetate and propionate have been shown to increase GLP-1 levels in just two hours.

Hunger and appetite are mediated by a complex chemical cascade that also heavily involves the brain. Cravings for certain foods, for example, are often driven by stress or other psychological factors rather than an actual need for nutrients. These chemical interactions occur via the gut-brain axis, which links the digestive system with the brain as well as the heart, liver, pancreas and other key organs. Chemical and electrical signals traveling across this axis allow your brain to regulate the energy the body devotes to digestion versus other goals.

One of the interesting aspects of GLP-1 usage is that they aren’t equally effective for everyone. Around 15% of users will experience no weight loss or change in blood sugar on a GLP-1 drug, and the reasons why are unclear. Of course, defining ‘response’ is a complex task, and it’s important to note the lack of standardization in this definition: some studies look only at weight, whereas others measure blood glucose as well, which can be measured a few different ways.

A hypothesis as to what differentiates responders from non-responders lies within the gut microbiome. A 2021 pilot study of diabetic patients found that GLP-1 responders have some common elements in their gut microbiomes, including higher levels of Bacteroides dorei and Lachnoclostridium. The efficacy of GLP-1 drugs may be influenced by the composition and activity of the gut microbiome. More research is needed to understand what role the microbiome plays in GLP-1 efficacy, but early signals suggest it may be a factor.

Yes. Whether weight loss occurs naturally with diet and exercise or via surgery such as a gastric bypass procedure, a ‘healthy weight’ microbiome is distinct from an obese microbiome. The relationship between gut microbiome composition and weight is likely bidirectional: for example, obesity can result in inflammation, which changes the gut environment and may favor more opportunistic bacteria. In the other direction, a healthy gut microbiome can produce a robust panel of short-chain fatty acids that help keep inflammation in check.

Yes, the microbiome can play a role in maintaining weight loss through changes in its composition and function. Post-weight loss, an increase in beneficial bacteria like Christensenellaceae and Akkermansia muciniphila—associated with metabolic health—can support energy regulation and reduce inflammation. Additionally, a diverse and stable gut microbiota can help stabilize metabolism, prevent fat storage, and regulate appetite. Probiotics, prebiotics, and a fiber-rich diet may further enhance these microbiome-mediated effects, aiding long-term weight maintenance.

Modifying the gut microbiome to support appetite regulation involves dietary and lifestyle interventions. Keep in mind that the gut and brain are working in tandem, so changes in your stress levels, diet, and environment will all influence your gut microbiome, which will in turn shape your risk for obesity. 

The first step to understand how your microbiome may predispose you to obesity comes from taking a microbiome test. A metagenomic shotgun sequencing test can show you the whole scope of organisms in your gut and provide context on the specific obesity and metabolic patterns you match. A balance of resistant starch can stimulate GLP-1 production without contributing to obesity.

Specific approaches will need to be personalized to your gut, but general advice includes maintaining a healthy intake of dietary fiber, avoiding processed foods and artificial sugars and prioritizing probiotic foods.